Bone marrow transplant is a complex procedure with significant risks. My passion is to make it so safe that anyone could have a successful transplant.
Where I see patients (2)
Selected research
-
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients.
Blood advances
-
Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia.
Clinical immunology (Orlando, Fla.)
-
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study.
The Journal of allergy and clinical immunology
Clinical trials
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
The cumulative incidence of Grade III-IV acute GVHD at Day 100 will be summarized by incidence curves. GVHD evaluations will be performed using standard criteria.37 Patients with graft rejection will be censored.
Recruiting
More about this studyJSP191 Antibody Targeting Conditioning in SCID Patients
The number of subjects experiencing dose limiting toxicities including adverse events and serious adverse events will be assessed.
Recruiting
More about this studyConditioning SCID Infants Diagnosed Early
Humoral immune reconstitution by 2 years post HCT, defined by specific antibody response to tetanus toxoid. Criteria for evaluation of humoral immune response are the following: Donor T cell chimerism ≥50% B cell count ≥50 cells/m...
Recruiting
More about this studyEBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Patients will be monitored for adverse events related to the infusion of EBV CTLs
Recruiting
More about this studyContact me
Saving future lives